About Advanced Technology Ventures
Advanced Technology Ventures is a venture capital firm founded in 1979. It is primarily based out of Menlo Park, United States. As of Feb 2019, Advanced Technology Ventures has invested in 105 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and HealthTech. Most recently it participated in the $***** Series E round of Nuvaira Overall, Advanced Technology Ventures portfolio has seen 6 IPOs and 57 acquisitions including key companies like Cepheid, Fuze and Verastem. A lot of funds co-invest with Advanced Technology Ventures, with names like DFJ sharing a substantial percentage of its portfolio. Advanced Technology Ventures has team of 5 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 7 more
Portfolio IPOs
Portfolio Acquisitions
Advanced Technology Ventures' List of Top Investments
Advanced Technology Ventures has a portfolio of 105 companies. Their most notable investments are in Planful and Planful.Their portfolio spans across United States, United Kingdom, France and 1 more locations. They have invested in Enterprise Applications, Life Sciences, HealthTech and 24 other sectors, across stages such as Series B, Series A and 7 more. Here is the list of top investments by Advanced Technology Ventures:1. Cepheid
Developer of molecular diagnostic testing solutions. The company offers a wide range of tests segregated into three major categories Hospital-acquired infection, Critical Infectious diseases (multi-drug resistant TB (MDR-TB), influenza, RSV, and Enteroviral meningitis) Sexual Health, and Genetic Test (30 Minute Test for Genetic Risk of Thrombosis).
Key facts about Cepheid
- Founded Year: 1996
- Location: Sunnyvale (United States)
- Annual Revenue: $500M - $1B as on Dec 31, 2015
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $19.1M
- Employee Count: 4,647 as on Sep 30, 2026
- Investors: CampVentures, Medtronic and 14 Others
- Latest Funding Round: Grant (prize money), Jul 30, 2021, $*****
- Highlight: Acquired
2. Fuze
Cloud-based unified communication software provider. It allows colleagues to chat, share, and comment on files, organize projects, and more via a web-based dashboard. Products include calling, meeting management, contact centre, and integrations. It is available on the Google Play Store and Apple App Store. The platform can be integrated with Office 365 and Google Chrome.
Key facts about Fuze
- Founded Year: 2006
- Location: Boston (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $543M
- Employee Count: 132 as on May 31, 2026
- Investors: TriplePoint Capital, TCV and 16 Others
- Latest Funding Round: Series F, Jan 20, 2021, $*****
- Highlight: Acquired
3. Verastem
Developer of small molecule inhibitors of signaling pathways for cancer therapy. The company focuses on developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation, Focal Adhesion Kinase (FAK), PI3K/mTOR, and Wnt.
Key facts about Verastem
- Founded Year: 2010
- Location: Needham (United States)
- Stage: Public
- Total Funding till date: $68.5M
- Employee Count: 177 as on Sep 30, 2026
- Investors: Venrock, RTW Investments and 19 Others
- Latest Funding Round: Post IPO, Apr 25, 2025, $*****
- Highlight: Public
Developer of therapeutics for cardiovascular and autoimmune diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism. Also, include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with the acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases, and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin’s lymphoma and chronic lymphocytic leukemia
Key facts about Portola Pharma
- Founded Year: 2003
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2019
- Stage: Acquired
- Total Funding till date: $296M
- Employee Count: 52 as on Sep 30, 2026
- Investors: Brookside Capital, T. Rowe Price and 22 Others
- Latest Funding Round: Post IPO, Jun 17, 2019, $*****
- Highlight: Acquired
Permanently eliminate treated fat with CoolSculpting, a non-surgical body contouring solution. It offers a way to reduce fat in areas like the stomach, love handles, thighs, and upper arms. The treatment works by freezing fat cells, which are then naturally eliminated from the body. It is a non-surgical alternative for individuals seeking to refine their body shape. It provides personalized treatment plans through consultations with healthcare providers. It offers a non-invasive approach to body contouring, allowing individuals to achieve a more sculpted physique without surgery or extensive downtime. It also offers loyalty programs and financing options to make treatments more accessible. It is backed by clinical research and has performed treatments worldwide. Keywords: body contouring, fat reduction, non-surgical, cryolipolysis, treatment areas, consultation, healthcare providers, personalized plans, loyalty program, financing, aesthetics, cosmetic procedure.
Key facts about CoolSculpting
- Founded Year: 2005
- Location: Pleasanton (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2016
- Stage: Public
- Employee Count: 89 as on Sep 30, 2026
- Investors: Aisling Capital and Advanced Technology Ventures
- Highlight: Public
Advanced Technology Ventures' Investments by Stage
Advanced Technology Ventures has made 34 investments in Series B stage with an average round size of $23.4M, 27 investments in Series A stage with an average round size of $12.8M and 15 investments in Series C stage with an average round size of $23.2M.Stage of entry | No. of Investments |
|---|---|
Series B | 34 |
Series A | 27 |
Series C | 15 |
Seed | 3 |
Series D | 2 |
Others | 4 |
Note: We have considered here, only first round of investments
Advanced Technology Ventures' Investments by Sector
Advanced Technology Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Enterprise Infrastructure, High Tech and HealthTech. Notably, it has invested in 82 Enterprise (B2B) companies, 79 Tech companies, 44 Software companies and at least 23 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Enterprise Applications | 29 |
Life Sciences | 27 |
Enterprise Infrastructure | 12 |
High Tech | 10 |
HealthTech | 7 |
Others | 61 |
Note: We have considered here, only first round of investments
Advanced Technology Ventures' Investments by Geography
Advanced Technology Ventures has made most investments in United States (82), followed by France where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 82 |
France | 1 |
India | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Advanced Technology Ventures' recent investments
Advanced Technology Ventures has not made any investment in 2026 so far.Here are the most recent investments by Advanced Technology Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 11, 2019 | United States | Series E | 7873 | [+8] | |
Jan 02, 2019 | United States | Series F | 8088 | [+7] | |
Aug 02, 2018 | United States | Series F | 3585 | [+4] | |
Jul 03, 2018 | United States | Series I | 9399 | [+5] | |
Jul 26, 2016 | United States | Series D | 7438 | [+5] |
IPOs and Publicly Listed companies in Advanced Technology Ventures' Portfolio
6 of Advanced Technology Ventures' portfolio companies have become public. Verastem got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2012 at marketcap of $202M and CoolSculpting got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $426M.Here are Advanced Technology Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 27, 2012 | Jul 14, 2011 | Series B | 1254 | |
Oct 19, 2011 | - | - | 8840 | |
Jul 09, 2011 | May 24, 2004 | Series B | 5871 | |
Oct 17, 2007 | May 06, 2003 | Series B | 3169 | |
Sep 14, 2007 | - | - | 4380 |
Acquired companies in Advanced Technology Ventures' Portfolio
57 companies from Advanced Technology Ventures' portfolio have been acquired. The most recent acquisition was Gynesonics in Oct 2024 by Hologic for $*****.Here are Advanced Technology Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 14, 2024 | Jan 24, 2007 | Series B | 8992 | |
Jun 06, 2024 | - | - | 6669 | |
Dec 12, 2023 | Apr 28, 2005 | Series B | 5553 | |
Dec 19, 2022 | Jul 21, 2008 | Post IPO | 2256 | |
Feb 09, 2022 | Feb 22, 2000 | Series B | 5164 |
Team profile of Advanced Technology Ventures
Advanced Technology Ventures has a team of 5 members including 2 Partners and 1 Venture Partner located in United States. Advanced Technology Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Advanced Technology Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Wellesley | - | ||
Partner | Russell Springs | - | ||
Venture Partner | Atherton | - |
Co-investors of Advanced Technology Ventures
Over the past 30 years, 461 investors have co-invested in Advanced Technology Ventures's portfolio companies. This includes funds and angels.
- Invested before Advanced Technology Ventures: Bessemer Venture Partners, OSTI and 58 others have invested in rounds before Advanced Technology Ventures. There are 2 companies where Bessemer Venture Partners has invested before Advanced Technology Ventures and 2 companies where OSTI has invested before Advanced Technology Ventures.
- Top Co-investors of Advanced Technology Ventures: 162 investors entered a company along with Advanced Technology Ventures. These include investors like DFJ (6 companies).
- Invested after Advanced Technology Ventures: A total of 239 investors have invested in Advanced Technology Ventures's portfolio after their investments. Top Investors include HHS (4 companies), Hercules Capital (4 companies) and Total (3 companies).
Recent News related to Advanced Technology Ventures
•
Advanced Technology Ventures Hit By Ransomware AttackValueWalk•Aug 04, 2021•Advanced Technology Ventures
•
Low Carbon Innovation Fund 2 invests in pH sensor company ANB SensorsPrivate Equity Wire•Jul 27, 2021•Turquoise, ANB Sensors, Low Carbon Innovation Fund, Hatch Blue and 2 others
•
EndoGastric Solutions Closes Series I Financing at a Total of $45 MillionBusiness Wire•May 28, 2019•EndoGastric Solutions, Canaan, Canepa Healthcare, Chicago Growth Partners and 4 others
•
Gynesonics Announces $75 Million FinancingBusiness Wire•Jan 03, 2019•Gynesonics, Abingworth, Bain Capital, Advanced Technology Ventures and 6 others
•
Actifio raises $100 mln from Crestline Investors, othersReuters•Aug 07, 2018•Actifio, Advanced Technology Ventures, Andreessen Horowitz, TCV and 5 others
•
EndoGastric Solutions Secures $30.5M In New FinancingFinSMEs•Jul 10, 2018•EndoGastric Solutions, Canaan, Canepa Healthcare, Chicago Growth Partners and 3 others
•
With $57.5B invested so far in 2018, VC funding for U.S. startups reaching ‘unprecedented levels’GeekWire•Jul 09, 2018•EndoGastric Solutions, Canaan, Canepa Healthcare, Chicago Growth Partners and 3 others
•
Machine Learning Healthcare Startups Get $10M In Seed FundingPYMNTS.com•Jun 04, 2018•Bessemer Venture Partners, Allena, HBM Partners, Frazier Healthcare Partners and 23 others
•
Blackstone and Fireside Acquire IMC from Bain CapitalCitybizlist•Jun 26, 2017•International Market Centers, Blackstone, Coskata, Advanced Technology Ventures and 8 others
•
Pfizer, Roche Embrace The Microbiome, Leading $43M Bet On Second GenomeForbes•Apr 20, 2016•Second Genome, Roche, Pfizer, Advanced Technology Ventures and 5 others
